These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 19149913

  • 1. Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China.
    Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Chen J.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):5-9. PubMed ID: 19149913
    [Abstract] [Full Text] [Related]

  • 2. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Wang YP, Chen J.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
    [Abstract] [Full Text] [Related]

  • 3. [Clinical importance of minimal residual disease testing in the therapy of childhood B-cell acute lymphoblastic leukemia].
    Ye QD, Gu LJ, Tang JY, Xue HL, Chen J, Pan C, Chen J, Dong L, Zhou M, Jiang LM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):333-6. PubMed ID: 18554462
    [Abstract] [Full Text] [Related]

  • 4. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H, Gu LJ, Xue HL, Tang JY, Chen J, Pan C, Chen J, Xu C, Dong L, Zhou M.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
    [Abstract] [Full Text] [Related]

  • 5. [Prognostic value of minimal residual disease in childhood B-cell acute lymphoblastic leukemia].
    Tie LJ, Gu LJ, Chen J, Jiang LM, Dong L, Pan C, Ye H, Song DL, Xue HL, Tang JY, Wang YP, Chen J.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):120-3. PubMed ID: 16732969
    [Abstract] [Full Text] [Related]

  • 6. [Correlation between karyotypic characteristics and treatment outcome in childhood acute lymphoblastic leukemia].
    Tie LJ, Gu LJ, Chen J, Dong L, Chen J, Pan C, Ye H, Xue HL, Tang JY, Wang YP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):339-43. PubMed ID: 16875587
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ, Gu LJ, Song DL, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Chen J, Wang YP, Zou JY.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1837-40. PubMed ID: 17054861
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR, Jin RM, Xu JW, Xiao Y, Zhou DF, Zhang ZQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 11; 10(1):1-4. PubMed ID: 18289459
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of prognostic variables in childhood acute myeloid leukemia].
    Gu LJ, Tie LJ, Xue HL, Tang JY, Chen J, Pan C, Chen J, Ye H, Wang YP, Dong L.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan 11; 27(1):10-3. PubMed ID: 16732931
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, Barth A, Borkhardt A, Peters C, Handgretinger R, Sykora KW, Holter W, Kabisch H, Klingebiel T, von Stackelberg A, ALL-REZ BFM Study Group.
    J Clin Oncol; 2009 Jan 20; 27(3):377-84. PubMed ID: 19064980
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
    Basso G, Veltroni M, Valsecchi MG, Dworzak MN, Ratei R, Silvestri D, Benetello A, Buldini B, Maglia O, Masera G, Conter V, Arico M, Biondi A, Gaipa G.
    J Clin Oncol; 2009 Nov 01; 27(31):5168-74. PubMed ID: 19805690
    [Abstract] [Full Text] [Related]

  • 17. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
    Wei W, Chen X, Zou Y, Chang L, An W, Wan Y, Liu T, Yang W, Chen Y, Guo Y, Zhu X.
    BMC Pediatr; 2015 Jul 15; 15():80. PubMed ID: 26174476
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A demographic study of the clinical significance of minimal residual disease in children with acute lymphoblastic leukemia.
    Levett D, Middleton P, Cole M, Reid MM.
    Med Pediatr Oncol; 2001 Mar 15; 36(3):365-71. PubMed ID: 11241438
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.